+ All Categories

Home > Health & Medicine > The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

Date post:	07-May-2015
Category:	Health & Medicine
Upload:	waleed-mahrous
View:	126 times
Download:	4 times

Download Report this document

Share this document with a friend

Description:

The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

Embed Size (px):

4

The changing role of beta-blocker therapy in patients with cirrhosis Phillip S. Ge and Bruce A. Runyon Journal of Hepatology Volume 60, Issue 3, Pages 643-653 (March 2014) DOI: 10.1016/j.jhep.2013.09.016 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Transcript

Page 1: The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

The changing role of beta-blocker therapy in patients with cirrhosis

Phillip S. Ge and Bruce A. Runyon

Journal of HepatologyVolume 60, Issue 3, Pages 643-653 (March 2014)

DOI: 10.1016/j.jhep.2013.09.016

Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

http://www.journal-of-hepatology.eu/article/S0168-8278(13)00676-4/abstract

http://www.journal-of-hepatology.eu/misc/terms

Page 2: The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

Fig. 1

Source: Journal of Hepatology 2014; 60:643-653 (DOI:10.1016/j.jhep.2013.09.016 )

Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

http://www.journal-of-hepatology.eu/article/S0168-8278(13)00676-4/abstract

http://www.journal-of-hepatology.eu/misc/terms

Page 3: The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

Fig. 2

Source: Journal of Hepatology 2014; 60:643-653 (DOI:10.1016/j.jhep.2013.09.016 )

Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

http://www.journal-of-hepatology.eu/article/S0168-8278(13)00676-4/abstract

http://www.journal-of-hepatology.eu/misc/terms

Page 4: The Changing Role of Beta-Blocker Therapy in Patients with Cirrhosis 2014

Source: Journal of Hepatology 2014; 60:643-653 (DOI:10.1016/j.jhep.2013.09.016 )

Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

http://www.journal-of-hepatology.eu/article/S0168-8278(13)00676-4/abstract

http://www.journal-of-hepatology.eu/misc/terms

Recommended

beta-blockers: Are they useful in arrhythmias? · important differences between different beta-blocker drugs. ... polymorphic ventricular tachycardia in children. A 7-year follow-up

PowerPoint Presentationmed.bpums.ac.ir/UploadedFiles/CourseFiles/آریتمی_و...digoxin, beta-blocker, calcium channel blocker—choice depend- ing on contractile state of left

Beta blocker use in cardiovascular disease · blockers, whereas lipophilic beta blockers have shorter half-lives and may require multiple daily dosing. Beta blocker mechanism of action

Bacterial translocation in cirrhosis - AISF · Bacterial translocation in cirrhosis P. Angeli Unit of Hepatic Emergencies and Liver Transplantation ... Laxatives Vitamin K Beta-blockers

Update on recent advances in treating beta-blocker and ... · in treating beta-blocker and calcium channel blocker overdose ... •Replace if below 2.8-3 ... Update on recent advances

Dr. onn akbar ali heart specialist kpj kajang heart failure and beta blocker

Health & Medicine

Decoding Complexities - forefrontcollabactivities.com · Gorre F, Vandekerckhove H. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Which beta-blocker,

Treating High Blood Pressure: Is a Beta-blocker Drug …consumerhealthchoices.org/.../BBD-BetaBlockers-2pg.pdf · Treating High Blood Pressure: Is a Beta-blocker Drug Right for You?

BETA BLOCKER TOXICITY

HIGH DOSE INSULIN IN BETA BLOCKER AND … 5C High-Dose Insulin Therapy (T...high dose insulin in beta blocker and calcium channel blocker overdose . ... blood sugar < 400 mg/dl

Selection of Antihypertensive Drug. ACE Inhibitor AT 1 Antagonist AT 1 Antagonist Diuretic Ca ++ Antagonist Beta Blocker Alpha Blocker Drug of choice.

Beta-Blocker For Reducing Cardiovascular Disease

Beta-Blocker Use and Morbidity from Chronic Lung Disease in Patients ... · ii Beta-Blocker Use and Morbidity from Chronic Lung Disease in Patients Undertaking Pulmonary Rehabilitation

Beta Blocker Overdose 11-08-09 REVISED · 2017. 8. 8. · Beta Blocker Overdose Simulation Case Heitz, Williams, Freeborn, Hannum, Fitch Page 3 D. Audiovisual Materials – See Appendix

“ beta blocker therapy has been shown to causefatnews.com/images/Messerli2003Betablockersnoteffective5...beta-blockers only have been shown to reduce events in male non-smokers.

Adrenergic Receptor...Bioactivity: Carteolol HCl is a non-selective beta blocker used to treat glaucoma. Bioactivity: Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker

Hypertension Management Seminar– executive summary · replace the beta-blocker in this case. When withdrawing a beta-blocker, step down the dose gradually . Beta-blockers should

EXCEMED Blended Educ ation 7th EMEA forum on ... · beta-blocker with a calcium antagonist. • Optimize the use of beta-blockers in patients with different cardiovascular complications